Chidamide in Combination With Abemaciclib and Endocrinotherapy（Doctor's Choice） in Breast Cancer Patients Previously Treated With Palbociclib

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

February 1, 2025

Study Completion Date

May 1, 2025

Conditions

Breast Cancer

Interventions

DRUG

Chidamide

10-30mg biw

DRUG

Abemaciclib

150mg or 100mg bid

DRUG

endocrinotherapy（doctor's choice）

According to the drug insert

Trial Locations (1)

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Biyun Wang, MD

OTHER